POLB vs. REDX, ETX, FUM, SBTX, TRX, COS, C4XD, DDDD, OKYO, and SAR
Should you be buying Poolbeg Pharma stock or one of its competitors? The main competitors of Poolbeg Pharma include Redx Pharma (REDX), e-therapeutics (ETX), Futura Medical (FUM), SkinBioTherapeutics (SBTX), Tissue Regenix Group (TRX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), OKYO Pharma (OKYO), and Sareum (SAR). These companies are all part of the "biotechnology" industry.
Poolbeg Pharma vs. Its Competitors
Poolbeg Pharma (LON:POLB) and Redx Pharma (LON:REDX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.
Poolbeg Pharma's return on equity of -32.56% beat Redx Pharma's return on equity.
1.2% of Poolbeg Pharma shares are held by institutional investors. Comparatively, 72.7% of Redx Pharma shares are held by institutional investors. 24.7% of Poolbeg Pharma shares are held by insiders. Comparatively, 18.4% of Redx Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Poolbeg Pharma has a beta of 2.11, suggesting that its share price is 111% more volatile than the S&P 500. Comparatively, Redx Pharma has a beta of -0.53, suggesting that its share price is 153% less volatile than the S&P 500.
Redx Pharma has higher revenue and earnings than Poolbeg Pharma. Poolbeg Pharma is trading at a lower price-to-earnings ratio than Redx Pharma, indicating that it is currently the more affordable of the two stocks.
In the previous week, Poolbeg Pharma's average media sentiment score of 0.00 equaled Redx Pharma'saverage media sentiment score.
Summary
Poolbeg Pharma beats Redx Pharma on 5 of the 9 factors compared between the two stocks.
Get Poolbeg Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding POLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Poolbeg Pharma Competitors List
Related Companies and Tools
This page (LON:POLB) was last updated on 7/25/2025 by MarketBeat.com Staff